Abstract
This review characterizes the relative effectiveness and safety of drug-eluting stents (DES) compared to bare metal stents. The data evaluated will include clinical and angiographic outcomes from randomized clinical trials as well as observational databases and registries including RESEARCH, e-Cypher, and DYNAMIC, which typically include a much broader spectrum of patients. In addition, specific patient subsets, including those patients with multivessel coronary disease, will be evaluated.
MeSH terms
-
Angioplasty, Balloon, Coronary
-
Blood Vessel Prosthesis Implantation
-
Coated Materials, Biocompatible / adverse effects
-
Coated Materials, Biocompatible / therapeutic use*
-
Coronary Angiography
-
Coronary Artery Disease / pathology
-
Coronary Artery Disease / therapy*
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Paclitaxel / therapeutic use
-
Randomized Controlled Trials as Topic
-
Registries
-
Safety
-
Sirolimus / therapeutic use
-
Stents* / adverse effects
-
Treatment Outcome
Substances
-
Coated Materials, Biocompatible
-
Immunosuppressive Agents
-
Paclitaxel
-
Sirolimus